Related Experiment Video
Updated: May 22, 2026

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact
Published on: July 17, 2016
Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro
B Barut1, D Chauhan, H Uchiyama
1Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
Insights
Interleukin-6 (IL-6) does not directly drive hairy cell leukemia (HCL) growth. However, IL-6 mediates tumor necrosis factor (TNF)-induced HCL DNA synthesis through an intracellular pathway.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Hairy cell leukemia (HCL) is a rare B-cell malignancy.
- The role of interleukin-6 (IL-6) in HCL proliferation is not fully understood.
Purpose of the Study:
- To investigate the direct and indirect roles of IL-6 in HCL cell growth.
- To determine if tumor necrosis factor (TNF)-induced HCL proliferation is IL-6-dependent.
Main Methods:
- Purified HCL cells were cultured in vitro.
- DNA synthesis was measured using various assays.
- IL-6 receptor (IL-6R) expression and IL-6 binding were assessed.
- IL-6 mRNA and protein levels were analyzed by Northern blotting and PCR.
- Neutralizing antibodies and antisense oligonucleotides were employed.
Main Results:
- Exogenous IL-6 did not stimulate HCL DNA synthesis.
- HCL cells expressed IL-6R and secreted low levels of IL-6.
- TNF significantly enhanced HCL DNA synthesis.
- TNF treatment increased IL-6 mRNA and protein production in HCL cells.
- IL-6 antisense oligonucleotide inhibited TNF-induced DNA synthesis and IL-6 secretion.
Conclusions:
- IL-6 does not directly promote HCL growth.
- IL-6 plays an indirect role in mediating TNF-induced HCL proliferation.
- An intracellular mechanism involving IL-6 mediates TNF's effect on HCL DNA synthesis.
Abstract:
The role of interleukin-6 (IL-6) in the growth of B cell derived hairy cell leukemia (HCL) was characterized. Purified hairy cells (HCs) did not increase DNA synthesis in vitro in response to exogenous IL-6; however, they expressed IL-6 receptor (IL-6R) mRNA and bound directly fluorochrome labeled IL-6. IL-6 mRNA was not detectable in tumor cells by Northern blotting, but was evident using PCR amplification. Although intracytoplasmic IL-6 protein was not demonstrable, HCs did secrete low levels of IL-6. Neutralizing antibody to IL-6 did not inhibit HC DNA synthesis. Since tumor necrosis factor (TNF) is a growth factor for HCL, we determined whether the TNF effect could be IL-6-mediated. TNF markedly augmented in vitro DNA synthesis by HCs. TNF did not alter IL-6R expression or IL-6 binding; however, IL-6 mRNA and IL-6 protein were detectable after 3-d culture of HCs with TNF. In addition, IL-6 secretion by HCs was markedly augmented by TNF. Finally, although neither IL-6 nor anti-IL-6 antibody altered TNF-induced DNA synthesis by HCs, IL-6 antisense oligonucleotide inhibited TNF-induced DNA synthesis and IL-6 secretion by HCs. Therefore, IL-6 does not directly affect the growth of HCL, but rather mediates TNF-induced DNA synthesis via an intracytoplasmic mechanism.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

